Catalin S Buhimschi

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Yale University, University of California. Active years: 2010-2024.

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 46(Granted Patents)

Location History:

New Haven, CT (US) (2010 - 2016)
Columbus, OH (US) (2018 - 2024)

Company Filing History:

University of California

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11953505 - Methods and compositions for detecting misfolded proteins (2024-04-09),

2. 11125758 - Methods and kits for detecting misfolded proteins (2021-09-21),

3. 11079392 - Methods and compositions for detecting misfolded proteins (2021-08-03),

4. 10324094 - Methods and compositions for detecting misfolded proteins (2019-06-18),

5. 10048276 - Methods and kits for detecting misfolded proteins (2018-08-14),

6. 9229009 - Methods and kits for detecting misfolded proteins (2016-01-05),

7. 8871448 - Diagnosis of preeclampsia (2014-10-28),

8. 8697367 - Markers for detection of complications resulting from in utero encounters (2014-04-15),

9. 8263342 - Urinary proteomic biomarker patterns in preeclampsia (2012-09-11),

10. 7935496 - Diagnosis of preeclampsia (2011-05-03),

11. 7727733 - Diagnosis of preeclampsia (2010-06-01),

Title: Catalin S Buhimschi: Innovator in Protein Detection

Introduction

Catalin S Buhimschi is a prominent inventor based in New Haven, CT (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of misfolded proteins. With a total of 11 patents to his name, Buhimschi's work has the potential to impact prenatal care and the diagnosis of preeclampsia.

Latest Patents

One of Buhimschi's latest patents focuses on methods and compositions for detecting misfolded proteins. This patent outlines various aspects and embodiments directed towards identifying subjects with misfolded proteins in their urine. For instance, the methods provided can determine whether a urine sample from a pregnant woman contains misfolded proteins. The presence of these proteins may indicate preeclampsia, a serious condition that can affect both the mother and the baby. Additionally, Buhimschi has developed methods, kits, and compounds related to the diagnosis, treatment, and prevention of preeclampsia.

Career Highlights

Throughout his career, Buhimschi has worked with esteemed institutions such as Yale University and the University of California. His research has garnered attention for its innovative approach to addressing critical health issues.

Collaborations

Buhimschi has collaborated with notable colleagues, including Irina Buhimschi and Hemant Tagare. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Catalin S Buhimschi's work in the detection of misfolded proteins represents a significant advancement in medical diagnostics. His contributions have the potential to improve prenatal care and enhance the understanding of preeclampsia.